Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hiroshi Takumida"'
Autor:
Yuriko Ueki, Manabu Suzuki, Yuriko Horikawa, Hiromu Watanabe, Yoh Yamaguchi, Chie Morita, Akinari Tsukada, Hiroshi Takumida, Yusaku Kusaba, Takashi Katsuno, Yoshie Tsujimoto, Keita Sakamoto, Masao Hashimoto, Junko Terada, Satoru Ishii, Jin Takasaki, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2731-2735 (2020)
Abstract Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICI
Externí odkaz:
https://doaj.org/article/25dedb817d3148c69a374d619a8d248d
Autor:
Takashi Katsuno, Manabu Suzuki, Momoko Morishita, Kazuki Kawajiri, Susumu Saito, Yuriko Horikawa, Yuriko Ueki, Yoh Yamaguchi, Hiroshi Takumida, Hiromu Watanabe, Chie Morita, Akinari Tsukada, Yusaku Kusaba, Yoshie Tsujimoto, Akane Ishida, Keita Sakamoto, Masao Hashimoto, Junko Terada, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama
Publikováno v:
Glob Health Med
High-flow nasal cannula (HFNC) can be effective in treating type 1 respiratory failure by reducing the severity of coronavirus disease 2019 (COVID-19). The purpose of this study was to assess the reduction of disease severity and safety of HFNC treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db0b1e41ec6129057219ed048f9c1b1
https://europepmc.org/articles/PMC9974223/
https://europepmc.org/articles/PMC9974223/
Autor:
Takashi Katsuno, Moto Kimura, Junko Terada-Hirashima, Yukumasa Kazuyama, Masato Ikeda, Ataru Moriya, Masami Kurokawa, Ayano Motohashi, Erina Isaka, Momoko Morishita, Kazuki Kawajiri, Kazuo Hakkaku, Susumu Saito, Yuriko Terayama, Yuriko Sugiura, Yoh Yamaguchi, Hiroshi Takumida, Hiromu Watanabe, Chie Morita, Akinari Tsukada, Yusaku Kusaba, Yoshie Tsujimoto, Akane Ishida, Keita Sakamoto, Masao Hashimoto, Manabu Suzuki, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama, Wataru Sugiura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f524a24ec3c2eb3082fa572211d0d86e
https://doi.org/10.2139/ssrn.4374997
https://doi.org/10.2139/ssrn.4374997
Autor:
Masayuki Hojo, Keita Sakamoto, Satoru Ishii, Masao Hashimoto, Shinyu Izumi, Jin Takasaki, Toru Igari, Manabu Suzuki, Mariko Tanaka, Hiroshi Takumida
Publikováno v:
Respiratory Investigation
A 70-year-old Japanese man contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and required oxygen to maintain oxygen saturation (>90%), 5 weeks after onset of coronavirus disease 2019 (COVID-19) symptoms. Transbronchial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e1d2452fba089da4499060b69755381
https://doi.org/10.1016/j.resinv.2020.12.005
https://doi.org/10.1016/j.resinv.2020.12.005
Autor:
Satoru Ishii, Junko Terada, Masayuki Hojo, Keita Sakamoto, Takashi Katsuno, Shinyu Izumi, Yuichiro Takeda, Yoh Yamaguchi, Yoshie Tsujimoto, Motoyasu Iikura, Haruhito Sugiyama, Yusaku Kusaba, Hiromu Watanabe, Masao Hashimoto, Jin Takasaki, Chie Morita, Yuriko Ueki, Yuriko Horikawa, Akinari Tsukada, Go Naka, Hiroshi Takumida, Manabu Suzuki
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2731-2735 (2020)
Thoracic Cancer
Thoracic Cancer
Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICIs is rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511f7fa6fc9a571b5ae2aee56c120d87
https://doaj.org/article/25dedb817d3148c69a374d619a8d248d
https://doaj.org/article/25dedb817d3148c69a374d619a8d248d
Autor:
Yuichiro Ohe, Ken Masuda, Hidehito Horinouchi, Yusuke Okuma, Noboru Yamamoto, Yuki Shinno, Yasushi Goto, Tatsuya Yoshida, Hiroshi Takumida
Publikováno v:
Cancer immunology, immunotherapy : CII. 71(3)
Introduction There are two treatment strategies for non-small cell lung cancer (NSCLC) exhibiting a high expression level of programmed death-ligand 1 (tumor proportion score ≥ 50%): pembrolizumab plus chemotherapy and monotherapy. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea38c0d01df06573dbc6b12d72a6bf91
https://pubmed.ncbi.nlm.nih.gov/34389874
https://pubmed.ncbi.nlm.nih.gov/34389874
Autor:
Masao Hashimoto, Hiroshi Takumida, Yusaku Kusaba, Ataru Moriya, Keita Sakamoto, Moto Kimura, Jin Takasaki, Takashi Katsuno, Shinyu Izumi, Masayuki Hojo, Akinari Tsukada, Kazuki Kawajiri, Yoh Yamaguchi, Hiromu Watanabe, Chie Morita, Ayano Motohashi, Momoko Morishita, Kazuo Hakkaku, Haruhito Sugiyama, Manabu Suzuki, Tohru Miyoshi-Akiyama, Susumu Saito, Yoshie Tsujimoto, Junko Terada
Publikováno v:
Infectious Diseases (London, England)
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Background The current gold standard in coronavirus disease (COVID-19) diagnostics is the real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in nas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fff2021e6cb563c2ee1a54d805592b3
https://pubmed.ncbi.nlm.nih.gov/33760699
https://pubmed.ncbi.nlm.nih.gov/33760699
Publikováno v:
Glob Health Med
This paper provides an overview of perioperative treatment for non-small cell lung cancer (NSCLC), including the current widespread use of cytotoxic anticancer agents, promising molecular targeted agents, and immuno-checkpoint inhibitors. Multiple cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55efe3c9ff85e50ce725c0ffabded434
https://europepmc.org/articles/PMC7936372/
https://europepmc.org/articles/PMC7936372/
Autor:
Yuichiro Takeda, Manabu Suzuki, Shuichiro Matsumoto, Hiroshi Takumida, Haruhito Sugiyama, Yuriko Horikawa, Keita Sakamoto, Takashi Katsuno, Yoshie Tsujimoto, Masao Hashimoto, Shinyu Izumi, Motoyasu Iikura, Tamaki Kakuwa, Shota Fujimoto, Hiromu Watanabe, Hirokazu Arai, Go Naka, Yuriko Ueki, Masayuki Hojo, Satoru Ishii, Yusaku Kusaba, Junko Terada, Jin Takasaki
Publikováno v:
Clinical respiratory physiology, exercise and functional imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f72b73243e5fdb83cdc2a31ae14dd918
https://doi.org/10.1183/13993003.congress-2020.2132
https://doi.org/10.1183/13993003.congress-2020.2132
Autor:
Motoyasu Iikura, Yuichiro Takeda, Keita Sakamoto, Masao Hashimoto, Tomoyuki Suzuki, Masayuki Hojo, Haruhito Sugiyama, Shinyu Izumi, Manabu Suzuki, Satoru Ishii, Go Naka, Hiroshi Takumida
Publikováno v:
Medicine. 100:e27943
Bronchoscopy is a procedure for diagnosis and treatment decision-making in patients with lung disease, especially those with acute respiratory failure. However, the optimal bronchoscopic method for patients with acute respiratory failure is not known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb57ba0e7310542294e0a9cad29e0a17
https://doi.org/10.1097/md.0000000000027943
https://doi.org/10.1097/md.0000000000027943